ECSP10010725A - Inhibidores de ciclopropil-polimerasa - Google Patents
Inhibidores de ciclopropil-polimerasaInfo
- Publication number
- ECSP10010725A ECSP10010725A EC2010010725A ECSP10010725A ECSP10010725A EC SP10010725 A ECSP10010725 A EC SP10010725A EC 2010010725 A EC2010010725 A EC 2010010725A EC SP10010725 A ECSP10010725 A EC SP10010725A EC SP10010725 A ECSP10010725 A EC SP10010725A
- Authority
- EC
- Ecuador
- Prior art keywords
- hydrogen
- alkyl
- compounds
- cyclopropil
- polymerase inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 9
- 239000001257 hydrogen Substances 0.000 abstract 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 101100439662 Arabidopsis thaliana CHR5 gene Proteins 0.000 abstract 1
- 239000001177 diphosphate Substances 0.000 abstract 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 abstract 1
- 235000011180 diphosphates Nutrition 0.000 abstract 1
- 150000002148 esters Chemical group 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 150000004712 monophosphates Chemical class 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000001226 triphosphate Substances 0.000 abstract 1
- 235000011178 triphosphate Nutrition 0.000 abstract 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Los compuestos de fórmula I:donde:R2 es hidrógeno o alquilo C1-C4;R3 y R4 son hidrógeno, -C(=O)R5, o -C(=O)CHR6-NH2; oR3 es hidrógeno y R4 es un éster de monofosfato, difosfato, o trifosfato; oR3 es hidrógeno, -C(=O)CHR5, o -C(=O)CHR6-NH2 y R4 escada R5 es hidrógeno, alquilo C1-C6, o cicloalquilo C3-C7;R6 es hidrógeno o alquilo C1-C6;R7 es fenilo opcionalmente sustituido; naftilo; o indolilo;R8 y R8' son hidrógeno, alquilo C1-C6, bencilo; oR8 y R8' combinados forman cicloalquilo C3-C7;R9 es alquilo C1-C6, bencilo, o fenilo opcionalmente sustituido;siempre que R2, R3 y R4 no sean todos hidrógeno;o su sal o solvato aceptable para uso farmacéutico;formulaciones farmacéuticas con los compuestos I; el uso de compuestos I, incluyendo los compuestos de fórmula I donde R2, R3 y R4 son todos hidrógeno, como inhibidores del VHC.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08159396 | 2008-07-01 | ||
| EP08171005 | 2008-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010725A true ECSP10010725A (es) | 2011-04-29 |
Family
ID=41095413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010725A ECSP10010725A (es) | 2008-07-01 | 2010-12-29 | Inhibidores de ciclopropil-polimerasa |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8431588B2 (es) |
| EP (1) | EP2141172B1 (es) |
| JP (1) | JP5624029B2 (es) |
| KR (1) | KR20110038683A (es) |
| CN (2) | CN105693794A (es) |
| AP (1) | AP2010005505A0 (es) |
| AR (1) | AR072428A1 (es) |
| AU (1) | AU2009266004B2 (es) |
| BR (1) | BRPI0913643A2 (es) |
| CA (1) | CA2729316A1 (es) |
| CL (1) | CL2010001634A1 (es) |
| CO (1) | CO6321255A2 (es) |
| DK (1) | DK2141172T3 (es) |
| EA (1) | EA022754B1 (es) |
| EC (1) | ECSP10010725A (es) |
| ES (1) | ES2396803T3 (es) |
| HK (1) | HK1226080A1 (es) |
| HR (1) | HRP20121068T1 (es) |
| IL (1) | IL209932A (es) |
| MX (1) | MX2010014493A (es) |
| NI (1) | NI201000231A (es) |
| PL (1) | PL2141172T3 (es) |
| PT (1) | PT2141172E (es) |
| SI (1) | SI2141172T1 (es) |
| SV (1) | SV2010003779A (es) |
| TW (1) | TW201012814A (es) |
| UY (1) | UY31950A (es) |
| WO (1) | WO2010000459A1 (es) |
| ZA (1) | ZA201009294B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG193820A1 (en) * | 2008-09-08 | 2013-10-30 | Novomer Inc | Polycarbonate polyol compositions and methods |
| UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
| TW201201815A (en) * | 2010-05-28 | 2012-01-16 | Gilead Sciences Inc | 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| PE20140039A1 (es) | 2010-12-30 | 2014-03-01 | Enanta Pharm Inc | Inhibidores de serina proteasa de hepatitis c a base de macrociclicos de fenantridina |
| CA2822556A1 (en) | 2010-12-30 | 2012-07-05 | Enanta Pharmaceuticals, Inc | Macrocyclic hepatitis c serine protease inhibitors |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| JP5845841B2 (ja) | 2011-11-18 | 2016-01-20 | 東芝ライテック株式会社 | 照明制御装置 |
| KR20140129019A (ko) | 2012-02-14 | 2014-11-06 | 유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 | 플라비비리다에 감염의 치료를 위한 스피로[2.4]헵탄 |
| EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
| RU2764767C2 (ru) | 2015-03-06 | 2022-01-21 | Атеа Фармасьютикалс, Инк. | β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-С-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ |
| RU2590952C1 (ru) * | 2015-05-26 | 2016-07-10 | Вячеслав Энгельсович Семёнов | Средство гепатопротекторного действия |
| LU100724B1 (en) | 2016-07-14 | 2018-07-31 | Atea Pharmaceuticals Inc | Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
| CN116036114A (zh) | 2016-09-07 | 2023-05-02 | 阿堤亚制药公司 | 用于rna病毒治疗的2’-取代的-n6-取代的嘌呤核苷酸 |
| CA3048033C (en) | 2017-02-01 | 2023-06-20 | Atea Pharmaceuticals, Inc. | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus |
| EP3773753A4 (en) | 2018-04-10 | 2021-12-22 | ATEA Pharmaceuticals, Inc. | TREATMENT OF PATIENTS INFECTED WITH THE HEPATITIS C VIRUS WITH CIRRHOSIS |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| IL308921A (en) | 2021-06-17 | 2024-01-01 | Atea Pharmaceuticals Inc | Combination anti-HCV therapy is beneficial |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69331643T2 (de) | 1992-12-29 | 2002-10-31 | Abbott Laboratories, Abbott Park | Zwischenprodukte zur Herstellung retroviraler proteasehemmenden Verbindungen |
| IL110752A (en) | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
| US5559158A (en) | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
| IL111991A (en) | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
| US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
| GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
| CN104193791A (zh) * | 2002-06-28 | 2014-12-10 | 埃迪尼克斯医药公司 | 用于治疗黄病毒感染的修饰的2’和3’-核苷前药 |
| CA2523083C (en) * | 2003-04-25 | 2014-07-08 | Gilead Sciences, Inc. | Antiviral phosphonate analogs |
| JP2008510748A (ja) * | 2004-08-23 | 2008-04-10 | エフ．ホフマン−ラ ロシュ アーゲー | 抗ウイルス４’−アジド−ヌクレオシド |
| CN101979397B (zh) * | 2006-10-10 | 2013-11-06 | 美迪维尔公司 | Hcv核苷类抑制剂 |
-
2009
- 2009-06-30 TW TW098121932A patent/TW201012814A/zh unknown
- 2009-06-30 AR ARP090102442A patent/AR072428A1/es not_active Application Discontinuation
- 2009-06-30 UY UY0001031950A patent/UY31950A/es unknown
- 2009-07-01 EA EA201170118A patent/EA022754B1/ru not_active IP Right Cessation
- 2009-07-01 AU AU2009266004A patent/AU2009266004B2/en not_active Ceased
- 2009-07-01 ES ES09008634T patent/ES2396803T3/es active Active
- 2009-07-01 EP EP09008634A patent/EP2141172B1/en active Active
- 2009-07-01 SI SI200930467T patent/SI2141172T1/sl unknown
- 2009-07-01 CN CN201610033092.2A patent/CN105693794A/zh active Pending
- 2009-07-01 CN CN200980125579.1A patent/CN102083845B/zh not_active Expired - Fee Related
- 2009-07-01 MX MX2010014493A patent/MX2010014493A/es active IP Right Grant
- 2009-07-01 PL PL09008634T patent/PL2141172T3/pl unknown
- 2009-07-01 BR BRPI0913643A patent/BRPI0913643A2/pt not_active IP Right Cessation
- 2009-07-01 KR KR1020117002345A patent/KR20110038683A/ko not_active Withdrawn
- 2009-07-01 CA CA2729316A patent/CA2729316A1/en not_active Abandoned
- 2009-07-01 US US12/999,263 patent/US8431588B2/en not_active Expired - Fee Related
- 2009-07-01 AP AP2010005505A patent/AP2010005505A0/xx unknown
- 2009-07-01 PT PT90086349T patent/PT2141172E/pt unknown
- 2009-07-01 JP JP2011515237A patent/JP5624029B2/ja not_active Expired - Fee Related
- 2009-07-01 WO PCT/EP2009/004748 patent/WO2010000459A1/en not_active Ceased
- 2009-07-01 DK DK09008634.9T patent/DK2141172T3/da active
-
2010
- 2010-12-12 IL IL209932A patent/IL209932A/en not_active IP Right Cessation
- 2010-12-22 SV SV2010003779A patent/SV2010003779A/es not_active Application Discontinuation
- 2010-12-23 CO CO10161808A patent/CO6321255A2/es not_active Application Discontinuation
- 2010-12-23 ZA ZA2010/09294A patent/ZA201009294B/en unknown
- 2010-12-23 NI NI201000231A patent/NI201000231A/es unknown
- 2010-12-29 EC EC2010010725A patent/ECSP10010725A/es unknown
- 2010-12-30 CL CL2010001634A patent/CL2010001634A1/es unknown
-
2012
- 2012-12-27 HR HRP20121068AT patent/HRP20121068T1/hr unknown
-
2016
- 2016-12-15 HK HK16114266.0A patent/HK1226080A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010725A (es) | Inhibidores de ciclopropil-polimerasa | |
| UY32308A (es) | Nucleótidos uracil ciclopropílicos | |
| HN2011003014A (es) | Neocleosidos uracilo espiro ocetano en fecha 16 de noviembre de 2011 se solicita por parte del titular de la invencion modificacion del titulo, ahora se denomina: espironucleosidos uraciclicos oxetanicos | |
| AR119698A2 (es) | Compuesto amida n-urea sustituida derivado de aminoácido | |
| ECSP109932A (es) | Compuestos de biciclolactama sustituida | |
| PE20130187A1 (es) | Bis(difluorometil) pirazoles como fungicidas | |
| CO6210729A2 (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona procedimientos para su preparacion y su uso como agente farmaceutico | |
| CO6290658A2 (es) | Derivados de azetidina y ciclobutano como inhibidores de jack | |
| AR087754A1 (es) | 6h-tieno[3,2,-f][1,2,4]triazolo[4,3-a][1,4]diazepina | |
| UY30527A1 (es) | Tetrazolilos macrociclicos como inhibidores de serina proteasa de hepatitis c | |
| ECSP077649A (es) | Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c | |
| CO6230986A2 (es) | Compuesto de 4-piridinona y su uso para cancer | |
| UY30391A1 (es) | Compuesto de oximilo aciclico inhibidores de proteasa de hepatitis c | |
| AR072803A1 (es) | Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes | |
| AR088414A1 (es) | Derivados sustituidos de indol | |
| AR085428A1 (es) | (3r,4r)-4-ciano-3,4-difenilbutanoatos sustituidos, procedimiento para su preparacion y su uso como herbicidas y reguladores de crecimiento de plantas | |
| AR085542A1 (es) | Compuestos de azaespirodecanona como inhibidores de hsl | |
| AR098854A1 (es) | 5-aril-1-imino-1-oxo-[1,2,4]tiadiazinas | |
| UY31262A1 (es) | Compuestos de biciclolactama sustituida | |
| CU20100017A7 (es) | Compuestos de biciclolactama sustituida | |
| AR112803A2 (es) | Derivados de piperazina como moduladores de piruvato quinasa m2 (pkm2) | |
| AR108805A1 (es) | Derivados de pirimidina como inhibidores de lrrk2 | |
| UY32895A (es) | Derivados acetilénicos de 5-fenilpirazolopiridina, su preparación y su aplicación terapéutica | |
| ECSP14013253A (es) | Derivados de pirrolopirimidina y purina | |
| CU20060172A7 (es) | 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos |